皮肤切片检查市场规模、份额及成长分析（按类型、适应症、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，全球皮肤切片检查市场规模将达到 353.5 亿美元，到 2025 年将达到 391.6 亿美元，到 2033 年将达到 889.6 亿美元，预测期（2026-2033 年）的复合年增长率为 10.8%。

由于新兴市场医疗基础设施的不断改进、皮肤癌发病率的上升以及对先进医疗服务需求的增长，皮肤切片检查市场预计将持续增长。皮肤切片检查在诊断各种皮肤疾病（例如恶性黑色素瘤、皮肤炎和干癣）方面发挥关键作用，从而推动了市场扩张。政府对医疗保健领域的投资不断增加以及医疗旅游的兴起，进一步促进了开发中国家的市场成长。此外，对微创医疗程序的需求也不断增长。目前已有针对100多种癌症的切片检查方法，人口增长、疾病意识的提高以及医疗费用支出的增加等因素都在影响着市场。然而，高昂的手术费用和对创新技术的认知不足等挑战可能会阻碍市场成长，但技术进步也带来了新的机会。

全球皮肤切片检查市场驱动因素

由于人工智慧软体的进步，全球皮肤切片检查市场正经历显着成长。这些软体能够辅助病理学家高效分析切片检查结果。这项创新技术简化了诊断流程，减少了延误，提高了市场效率。病理切片的数位化使得不同地区的病理学家和专家能够进行无缝的远端协作，从而促进影像和意见的共用。这种与专家的联繫对于病理服务资源有限的地区尤其重要。因此，这些数位技术的融合正在推动皮肤切片检查市场的整体成长。

限制全球皮肤切片检查市场的因素

切片检查手术的相关费用，包括术前评估和术后护理，对皮肤切片检查市场的成长构成重大挑战。中低收入者可能难以负担这些费用，尤其是在医疗预算有限的地区，他们更难以负担此类手术。这种经济负担导致人们在获得基本医疗服务方面存在不平等，特别是对于那些没有全面医疗保险的人来说。因此，经济困难的人可能会推迟切片检查，甚至错过重要的诊断。解决这些不平等问题对于确保人人享有公平的医疗服务以及促进市场的整体发展至关重要。

全球皮肤切片检查市场趋势

全球皮肤切片检查市场正呈现出显着的趋势，即医疗机构越来越多地采用综合切片检查技术，从而提高诊断准确性并改善患者照护。透过结合影像引导切片检查、内视镜检查和分子分析等技术，医疗机构能够从组织样本中获得更全面的资讯。这种多方面的方法有助于更深入地了解病理，使临床医生能够做出更准确的诊断并制定个人化的治疗方案。随着医疗专业人员日益认识到这些先进调查方法的价值，对专用切片检查设备的需求预计将强劲增长，这反映了整个行业向提升诊断能力的转变。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球皮肤切片检查市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 刮取切片检查
• 穿刺切片检查
• 切除切片检查

全球皮肤切片检查市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 皮肤癌
• 日光性角化症
• 皮肤炎
• 其他的

全球皮肤切片检查市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 诊所
• 诊断检查室
• 其他的

全球皮肤切片检查市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Becton, Dickinson and Company（USA）
• Cardinal Health（USA）
• Boston Scientific Corporation（USA）
• Cook Medical（USA）
• Hologic, Inc.（USA）
• Leica Biosystems Nussloch GmbH（Germany）
• Danaher Corporation（USA）
• Integra LifeSciences（USA）
• Innovia Medical（USA）
• DTR Medical Ltd（UK）
• Gallini Srl（Italy）
• KAI Group（Japan）
• AccuTec, Inc.（USA）
• Biomarker Technologies（China）
• Vernacare（UK）
• Freenome Holdings, Inc.（USA）
• Biodesix（USA）
• Exact Sciences Corporation（USA）
• GRAIL, Inc.（USA）
• GenMark Diagnostics（USA）

结论与建议

Global Skin Biopsy Market size was valued at USD 35.35 Billion in 2024 and is poised to grow from USD 39.16 Billion in 2025 to USD 88.96 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The skin biopsy market is poised for growth driven by enhanced healthcare infrastructure in emerging markets, rising incidences of skin cancer, and heightened demand for advanced medical services. Skin biopsies serve as a pivotal diagnostic tool for various skin conditions, including melanoma, dermatitis, and psoriasis, fueling the market's expansion. Increasing government investments in healthcare, along with the rise of medical tourism, further support this growth in developing economies. Demand for less invasive medical procedures is also on the rise. With over 100 types of biopsies available for different cancers, factors such as population growth, disease awareness, and improving healthcare spending are influencing the market. Nevertheless, challenges like high procedural costs and limited awareness of innovative techniques may hinder growth, although technological advancements present new opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Skin Biopsy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Skin Biopsy Market Segments Analysis

Global Skin Biopsy Market is segmented by type, indication, end user and region. Based on type, the market is segmented into shave biopsy, punch biopsy and excisional biopsy. Based on indication, the market is segmented into skin cancer, actinic keratosis, dermatitis and others. Based on end user, the market is segmented into hospital, clinics, diagnostic laboratories and other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Skin Biopsy Market

The Global Skin Biopsy market is experiencing significant growth due to advancements in AI-powered software that assists pathologists in efficiently analyzing biopsy results. This innovative technology streamlines the diagnostic process, reducing delays and enhancing market efficiency. By enabling the digitization of pathology slides, it allows for seamless remote collaboration among pathologists and specialists, facilitating the sharing of images and opinions regardless of geographic limitations. Such connectivity to specialized expertise is particularly beneficial in areas with limited access to pathology services. As a result, the integration of these digital advancements is driving overall growth in the skin biopsy market.

Restraints in the Global Skin Biopsy Market

The costs associated with biopsy procedures, encompassing pre-surgical assessments and postoperative care, pose a significant challenge to the growth of the skin biopsy market. Individuals with low to moderate incomes often find these expenses prohibitively high, making it difficult for them to afford such procedures, especially in healthcare systems with limited budgets. This financial burden creates disparities in access to essential health services, particularly for those lacking comprehensive insurance coverage. Consequently, individuals with financial constraints may experience delays in obtaining biopsies or even miss critical diagnoses altogether. Addressing these inequities is crucial to ensure equitable access to healthcare and promote overall market development.

Market Trends of the Global Skin Biopsy Market

The global skin biopsy market is witnessing a significant trend towards the adoption of integrated biopsy methods within healthcare settings, enhancing both diagnostic precision and patient care. By leveraging a combination of techniques such as image-guided biopsies, endoscopic procedures, and molecular analysis, healthcare facilities are obtaining comprehensive insights from tissue samples. This multi-faceted approach facilitates a deeper understanding of pathologies, thereby enabling clinicians to provide more accurate diagnoses and tailored treatment plans. As healthcare professionals increasingly recognize the value of these advanced methodologies, the demand for specialized biopsy devices is expected to experience robust growth, reflecting a shift towards improved diagnostic capabilities across the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Skin Biopsy Market Size by Type & CAGR (2026-2033)

• Market Overview
• Shave Biopsy
• Punch Biopsy
• Excisional Biopsy

Global Skin Biopsy Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Skin Cancer
• Actinic Keratosis
• Dermatitis
• Others

Global Skin Biopsy Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospital
• Clinics
• Diagnostic Laboratories
• Other

Global Skin Biopsy Market Size & CAGR (2026-2033)

• North America (Type, Indication, End User)
  • US
  • Canada
• Europe (Type, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leica Biosystems Nussloch GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovia Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DTR Medical Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gallini Srl (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KAI Group (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AccuTec, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomarker Technologies (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vernacare (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Freenome Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biodesix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GRAIL, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations